Predicate |
Object |
contentType |
Editorial|Comment |
endingPage |
1910 |
issn |
1935-5548 0149-5992 |
issueIdentifier |
8 |
pageRange |
1908-1910 |
publicationName |
Diabetes Care |
startingPage |
1908 |
bibliographicCitation |
Davidson MB. Counterpoint: postprandial glucose levels are not a clinically important treatment target. Diabetes Care. 2010 Aug;33(8):1908–10. PMID: 20668159; PMCID: PMC2909085. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12b82105c5a01b531b29941b6d06033e |
date |
2010-08-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://doi.org/10.2337/dc10-0712 https://pubmed.ncbi.nlm.nih.gov/PMC2909085 https://pubmed.ncbi.nlm.nih.gov/20668159 |
isPartOf |
https://portal.issn.org/resource/ISSN/1935-5548 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/3416 https://portal.issn.org/resource/ISSN/0149-5992 |
language |
English |
source |
https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/ |
title |
Counterpoint: Postprandial Glucose Levels Are Not a Clinically Important Treatment Target |
discusses |
http://id.nlm.nih.gov/mesh/M0002696 |